CCSA's Focus on Prescription Drugs
About 22% of Canadians over the age of 15 years old use psychoactive prescription drugs in some form according to the 2017 Canadian Tobacco, Alcohol and Drugs Survey. There is an urgent challenge to reduce the related harms of prescription drugs while ensuring timely and appropriate access to them for medical applications. This challenge is particularly pressing for opioids, but also for stimulants and sedatives. CCSA synthesizes research on demographic and use trends for psychoactive prescription drugs, provides targeted materials on associated issues, and fosters relationships that support prevention, harm reduction, treatment and recovery efforts.